id UFBA-2_f49403046990e6caccdfb1f1ab1183e6
oai_identifier_str oai:repositorio.ufba.br:ri/13434
network_acronym_str UFBA-2
network_name_str Repositório Institucional da UFBA
repository_id_str 1932
spelling Horovitz, Dafne Dain GandelmanMagalhães, Tatiana S. P. C.Acosta, Angelina XavierRibeiro, Erlane MarquesGiuliani, Liane de RossoPalhares, Durval BatistaKim, Chong AePaula, Ana Carolina deKerstenestzy, MarceloPianovski, Mara Albonei DudequeCosta, Maria Ione FerreiraSantos, Francisca C.Martins, Ana MariaAranda, Carolina SanchezCorrea Neto, JordãoHolanda, Gervina Brady MoreiraCardoso Junior, LaércioSilva, Carlos A. B. daBonatti, Renata Cristina FranzonRibeiro, Bethânia de Freitas RodriguesRodrigues, Maria do Carmo S.Llerena Junior, Juan ClintonHorovitz, Dafne Dain GandelmanMagalhães, Tatiana S. P. C.Acosta, Angelina XavierRibeiro, Erlane MarquesGiuliani, Liane de RossoPalhares, Durval BatistaKim, Chong AePaula, Ana Carolina deKerstenestzy, MarceloPianovski, Mara Albonei DudequeCosta, Maria Ione FerreiraSantos, Francisca C.Martins, Ana MariaAranda, Carolina SanchezCorrea Neto, JordãoHolanda, Gervina Brady MoreiraCardoso Junior, LaércioSilva, Carlos A. B. daBonatti, Renata Cristina FranzonRibeiro, Bethânia de Freitas RodriguesRodrigues, Maria do Carmo S.Llerena Junior, Juan Clinton2013-10-31T18:11:52Z20131096-7192http://repositorio.ufba.br/ri/handle/ri/13434v. 109, n. 1Texto completo. Acesso restrito. p. 62-69Background Mucopolysaccharidosis type VI (MPS VI) is a progressive, chronic and multisystem lysosomal storage disease with a wide disease spectrum. Clinical and biochemical improvements have been reported for MPS VI patients on enzyme replacement therapy (ERT) with rhASB (recombinant human arylsulfatase B; galsulfase, Naglazyme®, BioMarin Pharmaceutical Inc.), making early diagnosis and intervention imperative for optimal patient outcomes. Few studies have included children younger than five years of age. This report describes 34 MPS VI patients that started treatment with galsulfase before five years of age. Methods Data from patients who initiated treatment at < 5 years of age were collected from patients' medical records. Baseline and follow-up assessments of common symptoms that led to diagnosis and that were used to evaluate disease progression and treatment efficacy were evaluated. Results A significant negative correlation was seen with treatment with ERT and urinary GAG levels. Of those with baseline and follow-up growth data, 47% remained on their pre-treatment growth curve or moved to a higher percentile after treatment. Of the 9 patients with baseline and follow-up sleep studies, 5 remained unaffected and 1 patient initially with mild sleep apnea showed improvement. Data regarding cardiac, ophthalmic, central nervous system, hearing, surgical interventions and development are also reported. No patient discontinued treatment due to an adverse event and all that were treatment-emergent resolved. Conclusions The prescribed dosage of 1 mg/kg IV weekly with galsulfase ERT is shown to be safe and effective in slowing and/or improving certain aspects of the disease, although patients should be closely monitored for complications associated with the natural history of the disease, especially cardiac valve involvement and spinal cord compression. A long-term follow-up investigation of this group of children will provide further information on the benefits of early treatment as well as disease progression and treatment efficacy and safety in this young patient population.Submitted by Santiago Fabio (fabio.ssantiago@hotmail.com) on 2013-06-12T20:35:24Z No. of bitstreams: 1 44444444444444444.pdf: 651320 bytes, checksum: b04f6729f587dea82bdb8496e205fa34 (MD5)Approved for entry into archive by Rodrigo Meirelles (rodrigomei@ufba.br) on 2013-10-31T18:11:52Z (GMT) No. of bitstreams: 1 44444444444444444.pdf: 651320 bytes, checksum: b04f6729f587dea82bdb8496e205fa34 (MD5)Made available in DSpace on 2013-10-31T18:11:52Z (GMT). No. of bitstreams: 1 44444444444444444.pdf: 651320 bytes, checksum: b04f6729f587dea82bdb8496e205fa34 (MD5) Previous issue date: 2013SalvadorMolecular Genetics and Metabolismhttp://dx.doi.org/10.1016/j.ymgme.2013.02.014reponame:Repositório Institucional da UFBAinstname:Universidade Federal da Bahia (UFBA)instacron:UFBAMucopolysaccharidosis VIMPS VILysosomal storage disorderGalsulfaseEnzyme replacement therapyPediatricEnzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VIMolecular Genetics and Metabolisminfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article10000-01-01info:eu-repo/semantics/openAccessengORIGINAL44444444444444444.pdf44444444444444444.pdfapplication/pdf651320https://repositorio.ufba.br/bitstream/ri/13434/1/44444444444444444.pdfb04f6729f587dea82bdb8496e205fa34MD51LICENSElicense.txtlicense.txttext/plain1762https://repositorio.ufba.br/bitstream/ri/13434/2/license.txt1b89a9a0548218172d7c829f87a0eab9MD52TEXT44444444444444444.pdf.txt44444444444444444.pdf.txtExtracted texttext/plain41676https://repositorio.ufba.br/bitstream/ri/13434/3/44444444444444444.pdf.txt0861fe6e8a1c09f491bb1acb7691fa57MD53ri/134342022-07-05 14:03:15.103oai:repositorio.ufba.br:ri/13434VGVybW8gZGUgTGljZW7vv71hLCBu77+9byBleGNsdXNpdm8sIHBhcmEgbyBkZXDvv71zaXRvIG5vIHJlcG9zaXTvv71yaW8gSW5zdGl0dWNpb25hbCBkYSBVRkJBCgogICAgUGVsbyBwcm9jZXNzbyBkZSBzdWJtaXNz77+9byBkZSBkb2N1bWVudG9zLCBvIGF1dG9yIG91IHNldQpyZXByZXNlbnRhbnRlIGxlZ2FsLCBhbyBhY2VpdGFyIGVzc2UgdGVybW8gZGUgbGljZW7vv71hLCBjb25jZWRlIGFvClJlcG9zaXTvv71yaW8gSW5zdGl0dWNpb25hbCBkYSBVbml2ZXJzaWRhZGUgRmVkZXJhbCBkYSBCYWhpYSBvIGRpcmVpdG8KZGUgbWFudGVyIHVtYSBj77+9cGlhIGVtIHNldSByZXBvc2l077+9cmlvIGNvbSBhIGZpbmFsaWRhZGUsIHByaW1laXJhLCAKZGUgcHJlc2VydmHvv73vv71vLiBFc3NlcyB0ZXJtb3MsIG7vv71vIGV4Y2x1c2l2b3MsIG1hbnTvv71tIG9zIGRpcmVpdG9zIGRlIAphdXRvci9jb3B5cmlnaHQsIG1hcyBlbnRlbmRlIG8gZG9jdW1lbnRvIGNvbW8gcGFydGUgZG8gYWNlcnZvIGludGVsZWN0dWFsIGRlc3NhIFVuaXZlcnNpZGFkZS4gCgogICAgUGFyYSBvcyBkb2N1bWVudG9zIHB1YmxpY2Fkb3MgY29tIHJlcGFzc2UgZGUgZGlyZWl0b3MgZGUgZGlzdHJpYnVp77+977+9bywgZXNzZSB0ZXJtbyBkZSBsaWNlbu+/vWEgZW50ZW5kZSBxdWU6IAoKICAgIE1hbnRlbmRvIG9zICBkaXJlaXRvcyBhdXRvcmFpcywgcmVwYXNzYWRvcyBhIHRlcmNlaXJvcywgZW0gY2FzbyAKZGUgcHVibGljYe+/ve+/vWVzLCBvIHJlcG9zaXTvv71yaW8gcG9kZSByZXN0cmluZ2lyIG8gYWNlc3NvIGFvIHRleHRvIAppbnRlZ3JhbCwgbWFzIGxpYmVyYSBhcyBpbmZvcm1h77+977+9ZXMgc29icmUgbyBkb2N1bWVudG8gKE1ldGFkYWRvcyBkZXNjcml0aXZvcykuCgogRGVzdGEgZm9ybWEsIGF0ZW5kZW5kbyBhb3MgYW5zZWlvcyBkZXNzYSB1bml2ZXJzaWRhZGUgCmVtIG1hbnRlciBzdWEgcHJvZHXvv73vv71vIGNpZW5077+9ZmljYSBjb20gYXMgcmVzdHJp77+977+9ZXMgaW1wb3N0YXMgcGVsb3MgCmVkaXRvcmVzIGRlIHBlcmnvv71kaWNvcy4gCgogICAgUGFyYSBhcyBwdWJsaWNh77+977+9ZXMgZW0gaW5pY2lhdGl2YXMgcXVlIHNlZ3VlbSBhIHBvbO+/vXRpY2EgZGUgCkFjZXNzbyBBYmVydG8sIG9zIGRlcO+/vXNpdG9zIGNvbXB1bHPvv71yaW9zIG5lc3NlIHJlcG9zaXTvv71yaW8gbWFudO+/vW0gCm9zIGRpcmVpdG9zIGF1dG9yYWlzLCBtYXMgbWFudO+/vW0gbyBhY2Vzc28gaXJyZXN0cml0byBhbyBtZXRhZGFkb3MgCmUgdGV4dG8gY29tcGxldG8uIEFzc2ltLCBhIGFjZWl0Ye+/ve+/vW8gZGVzc2UgdGVybW8gbu+/vW8gbmVjZXNzaXRhIGRlIApjb25zZW50aW1lbnRvIHBvciBwYXJ0ZSBkZSBhdXRvcmVzL2RldGVudG9yZXMgZG9zIGRpcmVpdG9zLCBwb3IgCmVzdGFyZW0gZW0gaW5pY2lhdGl2YXMgZGUgYWNlc3NvIGFiZXJ0by4KCiAgICBFbSBhbWJvcyBvIGNhc28sIGVzc2UgdGVybW8gZGUgbGljZW7vv71hLCBwb2RlIHNlciBhY2VpdG8gcGVsbyAKYXV0b3IsIGRldGVudG9yZXMgZGUgZGlyZWl0b3MgZS9vdSB0ZXJjZWlyb3MgYW1wYXJhZG9zIHBlbGEgCnVuaXZlcnNpZGFkZS4gRGV2aWRvIGFvcyBkaWZlcmVudGVzIHByb2Nlc3NvcyBwZWxvIHF1YWwgYSBzdWJtaXNz77+9byAKcG9kZSBvY29ycmVyLCBvIHJlcG9zaXTvv71yaW8gcGVybWl0ZSBhIGFjZWl0Ye+/ve+/vW8gZGEgbGljZW7vv71hIHBvciAKdGVyY2Vpcm9zLCBzb21lbnRlIG5vcyBjYXNvcyBkZSBkb2N1bWVudG9zIHByb2R1emlkb3MgcG9yIGludGVncmFudGVzIApkYSBVRkJBIGUgc3VibWV0aWRvcyBwb3IgcGVzc29hcyBhbXBhcmFkYXMgcG9yIGVzdGEgaW5zdGl0dWnvv73vv71vLgo=Repositório InstitucionalPUBhttp://192.188.11.11:8080/oai/requestopendoar:19322022-07-05T17:03:15Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)false
dc.title.pt_BR.fl_str_mv Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI
dc.title.alternative.pt_BR.fl_str_mv Molecular Genetics and Metabolism
title Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI
spellingShingle Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI
Horovitz, Dafne Dain Gandelman
Mucopolysaccharidosis VI
MPS VI
Lysosomal storage disorder
Galsulfase
Enzyme replacement therapy
Pediatric
title_short Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI
title_full Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI
title_fullStr Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI
title_full_unstemmed Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI
title_sort Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI
author Horovitz, Dafne Dain Gandelman
author_facet Horovitz, Dafne Dain Gandelman
Magalhães, Tatiana S. P. C.
Acosta, Angelina Xavier
Ribeiro, Erlane Marques
Giuliani, Liane de Rosso
Palhares, Durval Batista
Kim, Chong Ae
Paula, Ana Carolina de
Kerstenestzy, Marcelo
Pianovski, Mara Albonei Dudeque
Costa, Maria Ione Ferreira
Santos, Francisca C.
Martins, Ana Maria
Aranda, Carolina Sanchez
Correa Neto, Jordão
Holanda, Gervina Brady Moreira
Cardoso Junior, Laércio
Silva, Carlos A. B. da
Bonatti, Renata Cristina Franzon
Ribeiro, Bethânia de Freitas Rodrigues
Rodrigues, Maria do Carmo S.
Llerena Junior, Juan Clinton
author_role author
author2 Magalhães, Tatiana S. P. C.
Acosta, Angelina Xavier
Ribeiro, Erlane Marques
Giuliani, Liane de Rosso
Palhares, Durval Batista
Kim, Chong Ae
Paula, Ana Carolina de
Kerstenestzy, Marcelo
Pianovski, Mara Albonei Dudeque
Costa, Maria Ione Ferreira
Santos, Francisca C.
Martins, Ana Maria
Aranda, Carolina Sanchez
Correa Neto, Jordão
Holanda, Gervina Brady Moreira
Cardoso Junior, Laércio
Silva, Carlos A. B. da
Bonatti, Renata Cristina Franzon
Ribeiro, Bethânia de Freitas Rodrigues
Rodrigues, Maria do Carmo S.
Llerena Junior, Juan Clinton
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Horovitz, Dafne Dain Gandelman
Magalhães, Tatiana S. P. C.
Acosta, Angelina Xavier
Ribeiro, Erlane Marques
Giuliani, Liane de Rosso
Palhares, Durval Batista
Kim, Chong Ae
Paula, Ana Carolina de
Kerstenestzy, Marcelo
Pianovski, Mara Albonei Dudeque
Costa, Maria Ione Ferreira
Santos, Francisca C.
Martins, Ana Maria
Aranda, Carolina Sanchez
Correa Neto, Jordão
Holanda, Gervina Brady Moreira
Cardoso Junior, Laércio
Silva, Carlos A. B. da
Bonatti, Renata Cristina Franzon
Ribeiro, Bethânia de Freitas Rodrigues
Rodrigues, Maria do Carmo S.
Llerena Junior, Juan Clinton
Horovitz, Dafne Dain Gandelman
Magalhães, Tatiana S. P. C.
Acosta, Angelina Xavier
Ribeiro, Erlane Marques
Giuliani, Liane de Rosso
Palhares, Durval Batista
Kim, Chong Ae
Paula, Ana Carolina de
Kerstenestzy, Marcelo
Pianovski, Mara Albonei Dudeque
Costa, Maria Ione Ferreira
Santos, Francisca C.
Martins, Ana Maria
Aranda, Carolina Sanchez
Correa Neto, Jordão
Holanda, Gervina Brady Moreira
Cardoso Junior, Laércio
Silva, Carlos A. B. da
Bonatti, Renata Cristina Franzon
Ribeiro, Bethânia de Freitas Rodrigues
Rodrigues, Maria do Carmo S.
Llerena Junior, Juan Clinton
dc.subject.por.fl_str_mv Mucopolysaccharidosis VI
MPS VI
Lysosomal storage disorder
Galsulfase
Enzyme replacement therapy
Pediatric
topic Mucopolysaccharidosis VI
MPS VI
Lysosomal storage disorder
Galsulfase
Enzyme replacement therapy
Pediatric
description Texto completo. Acesso restrito. p. 62-69
publishDate 2013
dc.date.accessioned.fl_str_mv 2013-10-31T18:11:52Z
dc.date.issued.fl_str_mv 2013
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufba.br/ri/handle/ri/13434
dc.identifier.issn.none.fl_str_mv 1096-7192
dc.identifier.number.pt_BR.fl_str_mv v. 109, n. 1
identifier_str_mv 1096-7192
v. 109, n. 1
url http://repositorio.ufba.br/ri/handle/ri/13434
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Molecular Genetics and Metabolism
publisher.none.fl_str_mv Molecular Genetics and Metabolism
dc.source.pt_BR.fl_str_mv http://dx.doi.org/10.1016/j.ymgme.2013.02.014
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFBA
instname:Universidade Federal da Bahia (UFBA)
instacron:UFBA
instname_str Universidade Federal da Bahia (UFBA)
instacron_str UFBA
institution UFBA
reponame_str Repositório Institucional da UFBA
collection Repositório Institucional da UFBA
bitstream.url.fl_str_mv https://repositorio.ufba.br/bitstream/ri/13434/1/44444444444444444.pdf
https://repositorio.ufba.br/bitstream/ri/13434/2/license.txt
https://repositorio.ufba.br/bitstream/ri/13434/3/44444444444444444.pdf.txt
bitstream.checksum.fl_str_mv b04f6729f587dea82bdb8496e205fa34
1b89a9a0548218172d7c829f87a0eab9
0861fe6e8a1c09f491bb1acb7691fa57
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)
repository.mail.fl_str_mv
_version_ 1801502505193963520